10 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or ObesityBody Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutritionNot yet recruitingPhase 32026-10-06NCT07861100
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Diseasecardiovascular disorder, hypertensive disorder, vascular disorderRecruitingPhase 32026-09-18NCT07181109
A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)Non Squamous Non Small Cell Lung CancerActive, not recruitingPhase 32026-09-10NCT06687369
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart AttackAcute Myocardial Infarction (AMI); Cardiovascular RiskActive, not recruitingPhase 32026-09-09NCT06118281
Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory PhenotypeDisease Attributes, Healthcare-Associated Pneumonia, Hospital Acquired Pneumonia, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, iatrogenic disease, lung disorder, nosocomial infection, pneumonia, respiratory system disorder, respiratory tract infectious disorderRecruitingPhase 32026-08-19NCT06269900
Male Breast Cancer: Understanding the Biology for Improved Patient CareNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingNot stated2026-05-12NCT01101425
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorderRecruitingPhase 32026-02-27NCT06532006
Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in GreeceSkin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorderActive, not recruitingNot stated2026-02-04NCT06247319
Assessing the Procalcitonin-guidance and Molecular-guided Diagnosis for Therapy of Severe Infections (the MODIFY Trial)Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response SyndromeActive, not recruitingPhase 32026-01-16NCT05909683
Fosfomycin I.v. for Treatment of Severely Infected PatientsBacterial Infections and Mycoses, Bone Diseases, Infectious, Brain Abscess, Cardiovascular Infections, Central Nervous System Bacterial Infections, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Intraabdominal Infections, Male Urogenital Diseases, Neuroinflammatory Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Skin and Connective Tissue Diseases, Soft Tissue Infections, Suppuration, Systemic Inflammatory Response Syndrome, Urogenital Diseases, abscess, bacterial endocarditis, bacterial infectious disease, bacterial infectious disease with sepsis, bacterial meningitis, bacterial pneumonia, bone disorder, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, endocarditis, gram-negative bacterial infections, gram-positive bacterial infections, heart disorder, lung disorder, meningitis, musculoskeletal system disorder, nervous system disorder, osteomyelitis, pneumonia, respiratory system disorder, respiratory tract infectious disorder, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, urinary system disorder, urinary tract infectionRecruitingNot stated2024-10-01NCT02979951